This might link to recurrent frameshift mutations in MBD4 found in a number of human cancers exhibiting MMR deficiency resulting in human MBD4 protein truncation at amino acid 313, which would presumably deconstruct the interaction function of intervening region in addition to loss of the glycosylase domain of MBD4. The gene discussed is MBD4; the disease is cancer.